- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
001360
KSC
Week ended 07 Aug 2026
Weekly Investor Report
SAMSUNG PHARM. Co., LTD. · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
1,302 KRW
5.1%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -22.4% below the Trend Line and sits at 13.7% of its 52-week range. The latest completed week returned 5.1%, after a -0.2% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
23
out of 100
Latest Close
1,302 KRW
7 Aug 2026
1W Return
5.1%
latest completed week
4W Return
-0.2%
short-term follow-through
12W Return
-23.5%
quarterly tape
Trend Breadth
46.2%
24 of 52 weeks active
Volume Ratio
0.8x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
5.1%
Latest completed week; four-week move -0.2%.
Indicator stack
25/27
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 41.13%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
3 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -22.4% below the Trend Line and sits at 13.7% of its 52-week range. The latest completed week returned 5.1%, after a -0.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0412-week average 0.28
12-week confirmation
Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.04Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -0.2% over four weeks, -23.5% over 12 weeks, and -19.1% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year24
Trend breadth46.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.30Latest activity-pressure read.
Pressure change4.2%Four-week change in activity pressure.
Leadership-37.27Latest relative-leadership reading.
RS change26.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 3 relevant articles.
0 positive · 3 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-43.9%Distance below the 52-week high.
13-week volatility5.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2615 weeks finished lower.
Best week+16.9%Week of 24 Apr.
Worst week-11.1%Week of 26 Jun.
Latest week+5.1%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains7
Flat weeks0
Modest losses5
Sharp losses10
Recent vol5.3%13-week weekly-return volatility.
Base vol7.8%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew6.0% / -4.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorKR Healthcare
4-week rank48 / 63
Group average4.4%
Trend breadth1.6%
Trend1.6%active weekly trend signals
MD9.5%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
IndustryKR Drug Manufacturers - Specialty & Generic
4-week rank33 / 44
Group average4.1%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD4.5%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape22/100
Trend, activity pressure, participation, and risk combine to a 22/100 tape read.
Indicator analysis11/100Latest 12-week confirmation: trend 1/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.04; No reversal markers Next-Week ExpectancyNegative 41.13%Next-week expectancy is negative with a 41.13% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 3 relevant articles.
Price to earnings forward of Nanchang Mineral Systems Co., Ltd. Class A – SZSE:001360 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1,302 KRW | 5.1% | 1,679 KRW | 1,741 KRW | -1.30 | -37.27 | 1.7M | Off |
| 31 Jul 2026 | 1,239 KRW | -2.7% | 1,684 KRW | 1,750 KRW | -1.27 | -44.30 | 2.3M | Off |
| 24 Jul 2026 | 1,274 KRW | -2.2% | 1,694 KRW | 1,759 KRW | -1.24 | -44.52 | 2.0M | Off |
| 17 Jul 2026 | 1,302 KRW | -0.2% | 1,702 KRW | 1,768 KRW | -1.32 | -45.35 | 1.5M | Off |
| 10 Jul 2026 | 1,305 KRW | -4.3% | 1,712 KRW | 1,778 KRW | -1.35 | -50.92 | 1.5M | Off |
| 3 Jul 2026 | 1,364 KRW | 7.3% | 1,730 KRW | 1,787 KRW | -1.40 | -53.48 | 385.5K | Off |
| 26 Jun 2026 | 1,271 KRW | -11.1% | 1,730 KRW | 1,795 KRW | -1.45 | -59.17 | 642.6K | Off |
| 19 Jun 2026 | 1,430 KRW | 3.9% | 1,733 KRW | 1,805 KRW | -1.41 | -58.21 | 911.4K | Off |
| 12 Jun 2026 | 1,376 KRW | -1.3% | 1,732 KRW | 1,815 KRW | -1.34 | -56.18 | 513.8K | Off |
| 5 Jun 2026 | 1,394 KRW | -8.0% | 1,735 KRW | 1,825 KRW | -1.20 | -56.85 | 764.1K | Off |
| 29 May 2026 | 1,515 KRW | -8.2% | 1,740 KRW | 1,834 KRW | -0.97 | -55.73 | 3.7M | Off |
| 22 May 2026 | 1,651 KRW | -2.9% | 1,740 KRW | 1,844 KRW | -0.58 | -48.92 | 3.9M | On |
| 15 May 2026 | 1,701 KRW | -6.8% | 1,736 KRW | 1,855 KRW | -0.05 | -45.84 | 6.2M | On |
| 8 May 2026 | 1,825 KRW | -10.1% | 1,731 KRW | 1,860 KRW | 0.18 | -42.80 | 7.0M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.